Stem cells in regenerative medicine

Stem cells in regenerative medicine

Stem cells are cells that have the ability to differentiate into various specialized cell types in the body. Their use in regenerative medicine offers significant potential for treating various diseases, injuries and conditions by replacing or regenerating damaged tissue.

Stem cell applications in regenerative medicine include :

  • Hematopoietic stem cell transplantation: Hematopoietic stem cells are used in the field of hematology to treat blood disorders, such as leukemia and sickle cell disease. These stem cells can be transplanted to regenerate the blood system in patients with these diseases, and among the biomarkers that can be used in the context of HSC transplantation for monitoring and management of this procedure; Blood groups and HLA typing performed to assess compatibility between donor and recipient. Flow cytometry often used to assess the cellular composition of bone marrow after transplantation. After transplantation, monitoring of hematopoietic growth factors such as granulocyte colony-stimulating factors (G-CSF) and granulocyte-macrophages (GM-CSF) can help support the rapid reconstitution of bone marrow.
  • Treatment of burns : Stem cells can be used in the treatment of burns to promote regeneration of damaged tissue. They secrete various growth drivers such as epidermal growth factors (EGF), fibroblast growth factors (FGF) and vascular endothelial growth factors (VEGF). The presence and activity of these factors in treated tissue can be measured to assess their impact on tissue regeneration, so analysis of collagen and extracellular matrix can help assess the quality of regeneration tissue.
  • Tissue engineering : Stem cells can be used for tissue engineering, such as the creation of artificial heart tissue. In this way, heart-specific contractile proteins such as cardiac troponin are used to assess the maturity of cardiac cells. For example, in bone tissue engineering, markers such as osteocalcin and RUNX2 are used to indicate differentiation into bone cells. Tissue engineering often involves the creation of an extracellular matrix that supports cell growth and function. Biomarkers such as collagen, fibronectin, and elastin can be used to assess the composition and quality of this matrix.
  • Production of artificial organs : Regenerative medicine is also exploring the possibility of producing artificial organs from stem cells. Measuring the expression of genes specific to the target tissue can indicate the extent to which stem cells have turned into functional cells of this tissue. Analysis of the expression of genes such as Sox9 for cartilage or FoxA2 for the liver is very important, and biomarkers related to blood vessel formation, such as the VEGF, and endothelial markers, are important too.
  • Regeneration of tissues and organs: Regeneration of tissues and organs: Stem cells can be used to regenerate damaged or failing tissues and organs. For example, they could be used to regenerate cardiac tissue after a heart attack, neurons to treat neurodegenerative diseases such as Parkinson, or cartilage to treat osteoarthritis.
  • Repair of spinal cord injuries: Stem cells could play a role in regenerating damaged spinal cord tissue, potentially helping to restore certain functions in paralyzed people. After an injury to the spinal cord, glial cells, in particular​​​​​​​ astrocytes, undergo reactive changes. Scar tissue can influence regeneration.​​​​​​​ Vimentin and GFAP (glial acidic fibrillary protein) are markers often used to assess astrocytic reactions. the light neurofilament protein (NFL) can indicate axonal degeneration and help monitor its progression.
  • Treatment of degenerative diseases: Stem cells offer hope for the treatment of degenerative diseases such as Alzheimer, sclerosis and other disorders of the central nervous system by promoting nerve cell regeneration and repairing damage.
  • Diabetes treatment: Pancreatic stem cells could eventually be used to regenerate beta-producing cells. insulin in the pancreas, offering a potential treatment for le type 1 diabetes.